Report Content
Chapter 1 Delivery Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Psoriasis treatment industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Drug class trends
2.1.4 Type trends
2.1.5 Route of administration trends
2.1.6 Distribution channel trends
Chapter 3 Psoriasis Treatment Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of psoriasis
3.2.1.2 Increasing awareness and improved diagnosis
3.2.1.3 Advancements in psoriasis treatment options
3.2.1.4 Growing geriatric population
3.2.1.5 Growing investments in R&D
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects and safety concerns
3.2.2.2 Limited insurance coverage
3.2.2.3 High cost of treatment
3.3 Growth potential analysis
3.3.1 By drug class
3.3.2 By type
3.3.3 By route of adminstration
3.3.4 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive analysis of major market players, 2022
4.5 Competitive positioning matrix, 2022
4.6 Strategy dashboard, 2022
4.7 Strategic outlook matrix, 2022
Chapter 5 Psoriasis Treatment Market Size and Forecast, By Drug class (USD Million)
5.1 Key trends, by drug class
5.2 Interleukins inhibitors
5.2.1 Secukinumab
5.2.2 Ustekinumab
5.2.3 Other interleukin inhibitors
5.3 TNF inhibitors
5.3.1 Etanercept
5.3.2 Certolizumab pegol
5.3.3 Adalimumab
5.3.4 Infiximab
5.3.5 Golimumab
5.4 Vitamin D analogs
5.4.1 Calcitriol
5.4.2 Calcipotriol
5.4.3 Tacalcitol
5.5 Other drug classes
Chapter 6 Psoriasis Treatment Market Size and Forecast, By Type (USD Million)
6.1 Key trends, by type
6.2 Psoriatic arthritis
6.3 Plaque psoriasis
6.4 Other types
Chapter 7 Psoriasis Treatment Market Size and Forecast, By Route of administration (USD Million)
7.1 Key trends, by route of administration
7.2 Parenteral
7.3 Topical
7.4 Oral
Chapter 8 Psoriasis Treatment Market Size and Forecast, By Distribution Channel (USD Million)
8.1 Key trends, by distribution channel
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Other distribution channels
Chapter 9 Psoriasis Treatment Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Amgen, Inc.
10.2 Merck & Co.
10.3 Biogen
10.4 Eli Lilly and Company
10.5 Astra Zeneca
10.6 LEO Pharma A/S
10.7 Novartis AG
10.8 AbbVie, Inc.
10.9 Johnson & Johnson Services, Inc.
10.10 Pfizer, Inc.
